ESTIMATION OF SAMARIUM-153 OXABIFORE THERAPY RESULTS OF METASTATIC BONE DISEASE IN COMBINED TREATMENT WITH BISPHOSPHONATES AND IN MONO REGIME BY SEMI-QUANTITATIVE ANALYZE OF WB BONE SCANS
Results of treatment of 54 patients: 43 female with breast cancer and 11 males with prostatic cancer with metastatic bone disease treated with using Sm-153 are assessed. According to semi-quantitative analyze of WB bone scans the most effects results were found in a group of patients who received co...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bashkir State Medical University
2017-01-01
|
| Series: | Креативная хирургия и онкология |
| Subjects: | |
| Online Access: | https://www.surgonco.ru/jour/article/view/11 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850050131312771072 |
|---|---|
| author | N. V. Rasulova D. T. Arybzhanov V. I. Lyubshin R. Karrer A. Bartl Sz. Wlodarczyk V. V. Krylov M. Kh. Khodjibekov |
| author_facet | N. V. Rasulova D. T. Arybzhanov V. I. Lyubshin R. Karrer A. Bartl Sz. Wlodarczyk V. V. Krylov M. Kh. Khodjibekov |
| author_sort | N. V. Rasulova |
| collection | DOAJ |
| description | Results of treatment of 54 patients: 43 female with breast cancer and 11 males with prostatic cancer with metastatic bone disease treated with using Sm-153 are assessed. According to semi-quantitative analyze of WB bone scans the most effects results were found in a group of patients who received combined therapy and there where regression of osteoblastic bone metastases in 84,2% of cases, progression is in 7,8%, the same number of patients had simultaneous process: progression and regression. However in patients who were treated with using Sm-153 oxabifore as mono therapy regression of bone metastases was found in 68% of cases, progression is in 25% of the patients and stabilization of metastatic bone disease is in 6,25% of cases. |
| format | Article |
| id | doaj-art-75b626bcfe9e48458afd432a1b9f61be |
| institution | DOAJ |
| issn | 2076-3093 2307-0501 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Bashkir State Medical University |
| record_format | Article |
| series | Креативная хирургия и онкология |
| spelling | doaj-art-75b626bcfe9e48458afd432a1b9f61be2025-08-20T02:53:33ZengBashkir State Medical UniversityКреативная хирургия и онкология2076-30932307-05012017-01-0101-2323810.24060/2076-3093-2014-0-1-2-32-3811ESTIMATION OF SAMARIUM-153 OXABIFORE THERAPY RESULTS OF METASTATIC BONE DISEASE IN COMBINED TREATMENT WITH BISPHOSPHONATES AND IN MONO REGIME BY SEMI-QUANTITATIVE ANALYZE OF WB BONE SCANSN. V. Rasulova0D. T. ArybzhanovV. I. LyubshinR. KarrerA. BartlSz. WlodarczykV. V. KrylovM. Kh. Khodjibekov1Republic Specialized Center of Surgery, Nuclear Medicine DepartmentRepublic Specialized Center of Surgery, Nuclear Medicine DepartmentResults of treatment of 54 patients: 43 female with breast cancer and 11 males with prostatic cancer with metastatic bone disease treated with using Sm-153 are assessed. According to semi-quantitative analyze of WB bone scans the most effects results were found in a group of patients who received combined therapy and there where regression of osteoblastic bone metastases in 84,2% of cases, progression is in 7,8%, the same number of patients had simultaneous process: progression and regression. However in patients who were treated with using Sm-153 oxabifore as mono therapy regression of bone metastases was found in 68% of cases, progression is in 25% of the patients and stabilization of metastatic bone disease is in 6,25% of cases.https://www.surgonco.ru/jour/article/view/11radionuclide therapysm-153 oxabiforebisphosphonatescombined therapysemi-quantitative analyze |
| spellingShingle | N. V. Rasulova D. T. Arybzhanov V. I. Lyubshin R. Karrer A. Bartl Sz. Wlodarczyk V. V. Krylov M. Kh. Khodjibekov ESTIMATION OF SAMARIUM-153 OXABIFORE THERAPY RESULTS OF METASTATIC BONE DISEASE IN COMBINED TREATMENT WITH BISPHOSPHONATES AND IN MONO REGIME BY SEMI-QUANTITATIVE ANALYZE OF WB BONE SCANS Креативная хирургия и онкология radionuclide therapy sm-153 oxabifore bisphosphonates combined therapy semi-quantitative analyze |
| title | ESTIMATION OF SAMARIUM-153 OXABIFORE THERAPY RESULTS OF METASTATIC BONE DISEASE IN COMBINED TREATMENT WITH BISPHOSPHONATES AND IN MONO REGIME BY SEMI-QUANTITATIVE ANALYZE OF WB BONE SCANS |
| title_full | ESTIMATION OF SAMARIUM-153 OXABIFORE THERAPY RESULTS OF METASTATIC BONE DISEASE IN COMBINED TREATMENT WITH BISPHOSPHONATES AND IN MONO REGIME BY SEMI-QUANTITATIVE ANALYZE OF WB BONE SCANS |
| title_fullStr | ESTIMATION OF SAMARIUM-153 OXABIFORE THERAPY RESULTS OF METASTATIC BONE DISEASE IN COMBINED TREATMENT WITH BISPHOSPHONATES AND IN MONO REGIME BY SEMI-QUANTITATIVE ANALYZE OF WB BONE SCANS |
| title_full_unstemmed | ESTIMATION OF SAMARIUM-153 OXABIFORE THERAPY RESULTS OF METASTATIC BONE DISEASE IN COMBINED TREATMENT WITH BISPHOSPHONATES AND IN MONO REGIME BY SEMI-QUANTITATIVE ANALYZE OF WB BONE SCANS |
| title_short | ESTIMATION OF SAMARIUM-153 OXABIFORE THERAPY RESULTS OF METASTATIC BONE DISEASE IN COMBINED TREATMENT WITH BISPHOSPHONATES AND IN MONO REGIME BY SEMI-QUANTITATIVE ANALYZE OF WB BONE SCANS |
| title_sort | estimation of samarium 153 oxabifore therapy results of metastatic bone disease in combined treatment with bisphosphonates and in mono regime by semi quantitative analyze of wb bone scans |
| topic | radionuclide therapy sm-153 oxabifore bisphosphonates combined therapy semi-quantitative analyze |
| url | https://www.surgonco.ru/jour/article/view/11 |
| work_keys_str_mv | AT nvrasulova estimationofsamarium153oxabiforetherapyresultsofmetastaticbonediseaseincombinedtreatmentwithbisphosphonatesandinmonoregimebysemiquantitativeanalyzeofwbbonescans AT dtarybzhanov estimationofsamarium153oxabiforetherapyresultsofmetastaticbonediseaseincombinedtreatmentwithbisphosphonatesandinmonoregimebysemiquantitativeanalyzeofwbbonescans AT vilyubshin estimationofsamarium153oxabiforetherapyresultsofmetastaticbonediseaseincombinedtreatmentwithbisphosphonatesandinmonoregimebysemiquantitativeanalyzeofwbbonescans AT rkarrer estimationofsamarium153oxabiforetherapyresultsofmetastaticbonediseaseincombinedtreatmentwithbisphosphonatesandinmonoregimebysemiquantitativeanalyzeofwbbonescans AT abartl estimationofsamarium153oxabiforetherapyresultsofmetastaticbonediseaseincombinedtreatmentwithbisphosphonatesandinmonoregimebysemiquantitativeanalyzeofwbbonescans AT szwlodarczyk estimationofsamarium153oxabiforetherapyresultsofmetastaticbonediseaseincombinedtreatmentwithbisphosphonatesandinmonoregimebysemiquantitativeanalyzeofwbbonescans AT vvkrylov estimationofsamarium153oxabiforetherapyresultsofmetastaticbonediseaseincombinedtreatmentwithbisphosphonatesandinmonoregimebysemiquantitativeanalyzeofwbbonescans AT mkhkhodjibekov estimationofsamarium153oxabiforetherapyresultsofmetastaticbonediseaseincombinedtreatmentwithbisphosphonatesandinmonoregimebysemiquantitativeanalyzeofwbbonescans |